Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy

American Journal of Kidney Diseases

Volumn 30, Issue 6, 1997, Pages 814-821

  Bhandari, Sunil ^a,b   Norfolk, Derek ^a   Brownjohn, Aleck ^a   Turney, John ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

EPO; Ferritin; Intravenous iron; RBC ferritin; Reticulocytes

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; IRON THERAPY; MALE; PATIENT MONITORING; RETICULOCYTE;

EID: 0030732221     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90087-1     Document Type: Article

References (14)

1. MacDougall IC, Hutton D, Cavill I, Coles GA, Williams JD: Poor response to treatment of renal anaemia with EPO corrected by iron given intravenously. BMJ 299:157-158, 1989
2. Anastassiades EG, Howarth D, Howarth J, Shanks D, Waters HM, Hyde K, Gaerung CG, Yin JAL, Gokal R: Monitoring of iron requirements in renal patients on EPO. Nephrol Dial Transplant 8:846-853, 1993
3. Van Wyck DB, Stivelman JC, Ruiz J, Kirlin LF, Katz MA, Ogden DA: Iron status in patients receiving erythropoietin for dialysis associated anaemia. Kidney Int 35:712-716, 1989
4. Milman N, Larsen L: Iron absorption in patients with chronic uraemia, undergoing regular haemodialysis. Acta Med Scand 199:113-119, 1976
5. Brown RD, Benfatta J, Gibson J, Kronenburg H: Red cell ferritin and iron stores in patients with chronic disease. Eur J Haematol 40:136-141, 1988
6. Bhandari S, Owda AK, Kendall RG, Moran N, Norfolk DR, Turney JH, Brownjohn AM: Red cell ferritin as a measure of iron deficiency anaemia in haemodialysis patients. Ren Fail (in press)
7. MacDougall IC, Hutton RD, Cavill I, Coles GA, Williams JD: Treating renal anaemia with recombinant human erythropoietin: Practical guidelines and a clinical algorithm. BMJ 300:155-159, 1990
8. Rosenberg ME: Role of transferrin measurement in monitoring iron status during human recombinant erythropoietin therapy. Nephrol Dial Transplant 21:81-90, 1992
9. Jacobs A, Miller F, Worwood M, Beamish MR: Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. BMJ 4:206-208, 1972
10. Brugnara C, Hipp MJ, Irving PJ, Lathrop H, Lee PA, Minchello EM, Winkelman J: Automated reticulocyte counting and the measurement of reticulocyte cellular indices. Am J Pathol 102:623-632, 1994
11. D'Onofrio G, Chirillo R, Zini G, Caenaro G, Ommasi M, Micciulli G: Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anaemia. Blood 85:818-823, 1995
12. Eschbach JW, Cook JD, Scribner BA, Finch CA: Iron balance in haemodialysis patients. Ann Intern Med 87:710-713, 1977
13. Gokal R, Millard PR, Weatherall DJ, Callener ST, Ledingham JGG, Oliver DO: Iron metabolism in haemodialysis patients. Q J Med 191:369-391, 1979
14. Moreb J, Popovitzer MM, Freidlander MM, Konijn AM, Hershko C: Evaluation of iron status in patients on chronic haemodialysis: Relative usefulness of bone marrow heamosiderosis, serum ferritin, transferrin saturation, MCV and red cell protoporphyrin. Nephron 35:196-200, 1983